UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Updates on the use of liposomes for active tumor targeting in cancer therapy

Nanomedicine (London, England), 2020-02, Vol.15 (3), p.303-318

2020

Volltextzugriff (PDF)

MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside

World journal of gastroenterology : WJG, 2018-07, Vol.24 (27), p.2949-2973

2018

Volltextzugriff (PDF)

Circumvention of multi-drug resistance of cancer cells by Chinese herbal medicines

Chinese medicine, 2010-07, Vol.5 (1), p.26-26, Article 26

2010

Volltextzugriff (PDF)

Editorial: The role of STAT3 signaling pathway in tumor progression

Frontiers in oncology, 2023-02, Vol.13, p.1151862-1151862

2023

Volltextzugriff (PDF)

Editorial: The Evolving Landscape, Clinical Implications, and Future Perspective of Biomarkers in Gastrointestinal Cancers

Frontiers in oncology, 2022-05, Vol.12, p.895231-895231

2022

Volltextzugriff (PDF)

Abstract 6326: Global changes in alternative mRNA polyadenylation profile promote the development of multidrug resistance (MDR) to chemotherapy in colon cancer

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.6326-6326

To, Kenneth KW

2020

Volltextzugriff (PDF)

Abstract LB-263: miR-181a downregulation allows simultaneous overexpression of ABCG2 and induction of autophagy to mediate multidrug resistance in colon cancer

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.LB-263-LB-263

To, Kenneth KW

2019

Volltextzugriff (PDF)

MicroRNA: a prognostic biomarker and a possible druggable target for circumventing multidrug resistance in cancer chemotherapy

Journal of biomedical science, 2013-12, Vol.20 (1), p.99-99, Article 99

To, Kenneth K W

2013

Volltextzugriff (PDF)

Drug combination approach to overcome resistance to EGFR tyrosine kinase inhibitors in lung cancer

Cancer letters, 2017-10, Vol.405, p.100-110

2017

Volltextzugriff (PDF)

Flavonoids potentiated anticancer activity of cisplatin in non-small cell lung cancer cells in vitro by inhibiting histone deacetylases

Life sciences (1973), 2020-10, Vol.258, p.118211, Article 118211

2020

Volltextzugriff (PDF)

The RNA Binding Protein HuR: a Promising Drug Target for Anticancer Therapy

Current cancer drug targets, 2019-01, Vol.19 (5), p.382-399

2019

Volltextzugriff (PDF)

Abstract 1969: Cancer exosomes as a new mediator to spread drug resistance to EGFR tyrosine kinase inhibitors

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.1969-1969

2018

Volltextzugriff (PDF)

Abstract 3814: Overcoming multidrug resistance (MDR) in colorectal cancer by modulating exosome-mediated transfer of MDR transporter regulatory machineries

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.3814-3814

2019

Volltextzugriff (PDF)

A novel miR‐203‐DNMT3b‐ABCG2 regulatory pathway predisposing colorectal cancer development

Molecular carcinogenesis, 2017-02, Vol.56 (2), p.464-477

2017

Volltextzugriff (PDF)

Micellar delivery of dasatinib for the inhibition of pathologic cellular processes of the retinal pigment epithelium

Colloids and surfaces, B, Biointerfaces, 2016-04, Vol.140, p.278-286

2016

Volltextzugriff (PDF)

Abstract LB-126: PPARgamma agonists sensitize PTEN-deficient lung cancer cells resistant to EGFR tyrosine kinase inhibitors

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.LB-126-LB-126

2017

Volltextzugriff (PDF)

Abstract 4737: New platinum (Pt)-based anticancer agents, bearing a PtN2SO coordination core, for treating advanced melanoma

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.4737-4737

2016

Volltextzugriff (PDF)

Constitutive AhR activation leads to concomitant ABCG2-mediated multidrug resistance in cisplatin-resistant esophageal carcinoma cells

Molecular carcinogenesis, 2012-06, Vol.51 (6), p.449-464

2012

Volltextzugriff (PDF)

Expression and activity of ABCG2, but not ABCB1 or OATP1B1, are associated with cholesterol levels: evidence from in vitro and in vivo experiments

Pharmacogenomics, 2014-06, Vol.15 (8), p.1091-1104

2014

Volltextzugriff (PDF)

Suppression of Hypoxia-inducible Factor 1α (HIF-1α) Transcriptional Activity by the HIF Prolyl Hydroxylase EGLN1

The Journal of biological chemistry, 2005-11, Vol.280 (45), p.38102-38107

2005

Volltextzugriff (PDF)

Histone Modifications at the ABCG2 Promoter following Treatment with Histone Deacetylase Inhibitor Mirror Those in Multidrug-Resistant Cells

Molecular cancer research, 2008-01, Vol.6 (1), p.151-164

2008

Volltextzugriff (PDF)

Increased expression of activated endothelial nitric oxide synthase contributes to antiandrogen resistance in prostate cancer cells by suppressing androgen receptor transactivation

Cancer letters, 2013-01, Vol.328 (1), p.83-94

2013

Volltextzugriff (PDF)

Telmisartan increases systemic exposure to rosuvastatin after single and multiple doses, and in vitro studies show telmisartan inhibits ABCG2-mediated transport of rosuvastatin

European journal of clinical pharmacology, 2016-12, Vol.72 (12), p.1471-1478

2016

Volltextzugriff (PDF)

The ABCG2 transporter and its relations with the pharmacokinetics, drug interaction and lipid-lowering effects of statins

Expert opinion on drug metabolism & toxicology, 2011-01, Vol.7 (1), p.49-62

2011

Volltextzugriff (PDF)

Reduced Expression of DNA Topoisomerase I in SF295 Human Glioblastoma Cells Selected for Resistance to Homocamptothecin and Diflomotecan

Molecular pharmacology, 2008-02, Vol.73 (2), p.490-497

2008

Volltextzugriff (PDF)

1 – 25 von 5.995

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(5.240)
Mit Volltextzugriff
(4.703)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(5.994)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(5.250)
Life Sciences & Biomedicine
(3.744)
Humans
(1.950)
Biological And Medical Sciences
(1.540)
Animals
(1.185)
Male
(1.145)
Physical Sciences
(1.135)
Female
(1.034)
Medical Sciences
(925)
Social Sciences
(781)
Chemistry
(674)
Technology
(655)
Fundamental And Applied Biological Sciences. Psychology
(638)
Adult
(539)
Middle Aged
(480)
Exact Sciences And Technology
(479)
Aged
(363)
Biochemistry & Molecular Biology
(353)
Pharmacology & Pharmacy
(336)
Mice
(334)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(3.188)
Ingenta.com
(2.243)
EZB Electronic Journals Library
(1.899)
Ovid
(1.782)
Publisher
(1.702)
Elsevier ScienceDirect Journals Complete
(1.264)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(1.012)
JSTOR
(805)
Wiley-Blackwell Journals
(763)
IngentaConnect Journals
(726)
Wiley Online Library
(557)
Oxford Journals
(322)
2022 ECC(Springer)
(269)
Sage
(231)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(218)
Taylor & Francis Journals
(217)
Taylor & Francis
(207)
Business Source Ultimate【Trial: -2024/12/31】【Remote access available】
(202)
Taylor & Francis Journals Complete
(196)
Psychology & Behavioral Sciences Collection (EBSCO)
(166)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Updates on the use of liposomes for active tumor targeting in cancer therapy

MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside

Circumvention of multi-drug resistance of cancer cells by Chinese herbal medicines

Editorial: The role of STAT3 signaling pathway in tumor progression

Editorial: The Evolving Landscape, Clinical Implications, and Future Perspective of Biomarkers in Gastrointestinal Cancers

Abstract 6326: Global changes in alternative mRNA polyadenylation profile promote the development of multidrug resistance (MDR) to chemotherapy in colon cancer

Abstract LB-263: miR-181a downregulation allows simultaneous overexpression of ABCG2 and induction of autophagy to mediate multidrug resistance in colon cancer

MicroRNA: a prognostic biomarker and a possible druggable target for circumventing multidrug resistance in cancer chemotherapy

Drug combination approach to overcome resistance to EGFR tyrosine kinase inhibitors in lung cancer

Flavonoids potentiated anticancer activity of cisplatin in non-small cell lung cancer cells in vitro by inhibiting histone deacetylases

The RNA Binding Protein HuR: a Promising Drug Target for Anticancer Therapy

Abstract 1969: Cancer exosomes as a new mediator to spread drug resistance to EGFR tyrosine kinase inhibitors

Abstract 3814: Overcoming multidrug resistance (MDR) in colorectal cancer by modulating exosome-mediated transfer of MDR transporter regulatory machineries

A novel miR‐203‐DNMT3b‐ABCG2 regulatory pathway predisposing colorectal cancer development

Micellar delivery of dasatinib for the inhibition of pathologic cellular processes of the retinal pigment epithelium

Abstract LB-126: PPARgamma agonists sensitize PTEN-deficient lung cancer cells resistant to EGFR tyrosine kinase inhibitors

Abstract 4737: New platinum (Pt)-based anticancer agents, bearing a PtN2SO coordination core, for treating advanced melanoma

Constitutive AhR activation leads to concomitant ABCG2-mediated multidrug resistance in cisplatin-resistant esophageal carcinoma cells

Expression and activity of ABCG2, but not ABCB1 or OATP1B1, are associated with cholesterol levels: evidence from in vitro and in vivo experiments

Suppression of Hypoxia-inducible Factor 1α (HIF-1α) Transcriptional Activity by the HIF Prolyl Hydroxylase EGLN1

Histone Modifications at the ABCG2 Promoter following Treatment with Histone Deacetylase Inhibitor Mirror Those in Multidrug-Resistant Cells

Increased expression of activated endothelial nitric oxide synthase contributes to antiandrogen resistance in prostate cancer cells by suppressing androgen receptor transactivation

Telmisartan increases systemic exposure to rosuvastatin after single and multiple doses, and in vitro studies show telmisartan inhibits ABCG2-mediated transport of rosuvastatin

The ABCG2 transporter and its relations with the pharmacokinetics, drug interaction and lipid-lowering effects of statins

Reduced Expression of DNA Topoisomerase I in SF295 Human Glioblastoma Cells Selected for Resistance to Homocamptothecin and Diflomotecan

Suchergebnisse filtern